These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 9631148
1. Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa. Marseille E, Kahn JG, Saba J. AIDS; 1998 May 28; 12(8):939-48. PubMed ID: 9631148 [Abstract] [Full Text] [Related]
2. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB. Lancet; 1999 Sep 04; 354(9181):803-9. PubMed ID: 10485721 [Abstract] [Full Text] [Related]
3. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting. Mansergh G, Haddix AC, Steketee RW, Nieburg PI, Hu DJ, Simonds RJ, Rogers M. JAMA; 1996 Jul 10; 276(2):139-45. PubMed ID: 8656506 [Abstract] [Full Text] [Related]
4. Cost-effectiveness of zidovudine to prevent mother-to-child transmission of HIV in sub-Saharan Africa. Mansergh G, Haddix AC, Steketee RW, Simonds RJ. JAMA; 1998 Jul 01; 280(1):30-1. PubMed ID: 9660355 [No Abstract] [Full Text] [Related]
5. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa. Wilkinson D, Floyd K, Gilks CF. S Afr Med J; 2000 Aug 01; 90(8):794-8. PubMed ID: 11022629 [Abstract] [Full Text] [Related]
6. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Petra Study Team. Lancet; 2002 Apr 06; 359(9313):1178-86. PubMed ID: 11955535 [Abstract] [Full Text] [Related]
7. Evaluating the cost-effectiveness of combination antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Uganda. Kuznik A, Lamorde M, Hermans S, Castelnuovo B, Auerbach B, Semeere A, Sempa J, Ssennono M, Ssewankambo F, Manabe YC. Bull World Health Organ; 2012 Aug 01; 90(8):595-603. PubMed ID: 22893743 [Abstract] [Full Text] [Related]
8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Cochrane Database Syst Rev; 2011 Jul 06; (7):CD003510. PubMed ID: 21735394 [Abstract] [Full Text] [Related]
9. A review of studies assessing the costs and consequences of interventions to reduce mother-to-child HIV transmission in sub-Saharan Africa. Scotland GS, van Teijlingen ER, van der Pol M, Smith WC. AIDS; 2003 May 02; 17(7):1045-52. PubMed ID: 12700455 [Abstract] [Full Text] [Related]
10. Incremental cost-effectiveness of two zidovudine regimens to prevent perinatal HIV transmission in the United States. Pinkerton SD, Holtgrave DR, Layde PM. Prev Med; 2000 Jan 02; 30(1):64-9. PubMed ID: 10642461 [Abstract] [Full Text] [Related]
11. Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting. Rely K, Bertozzi SM, Avila-Figueroa C, Guijarro MT. Health Policy Plan; 2003 Sep 02; 18(3):290-8. PubMed ID: 12917270 [Abstract] [Full Text] [Related]
12. Paying to waste lives: the affordability of reducing mother-to-child transmission of HIV in South Africa. Skordis J, Nattrass N. J Health Econ; 2002 May 02; 21(3):405-21. PubMed ID: 12022266 [Abstract] [Full Text] [Related]
13. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening. Mauskopf JA, Paul JE, Wichman DS, White AD, Tilson HH. JAMA; 1996 Jul 10; 276(2):132-8. PubMed ID: 8656505 [Abstract] [Full Text] [Related]
14. [The reduction of mother-child transmission of HIV infection in developing countries: potential intervention strategies, obstacles to implementation and perspectives. The Reduction of Mother-Child Transmission of HIV Infection in Africa Group]. Meda N, Msellati P, Welffens-Ekra C, Cartoux M, Leroy V, Van de Perre P, Salamon R. Sante; 1997 Jul 10; 7(2):115-25. PubMed ID: 9273118 [Abstract] [Full Text] [Related]
15. Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries. Sweat MD, O'Reilly KR, Schmid GP, Denison J, de Zoysa I. AIDS; 2004 Aug 20; 18(12):1661-71. PubMed ID: 15280777 [Abstract] [Full Text] [Related]
17. Costs and benefits of multidrug, multidose antiretroviral therapy for prevention of mother-to-child transmission of HIV in the Dominican Republic. Schmidt NC, Roman-Pouriet J, Fernandez AD, Beck-Sagué CM, Leonardo-Guerrero J, Nicholas SW. Int J Gynaecol Obstet; 2012 Mar 20; 116(3):219-22. PubMed ID: 22196992 [Abstract] [Full Text] [Related]
19. Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa. Price JT, Wheeler SB, Stranix-Chibanda L, Hosek SG, Watts DH, Siberry GK, Spiegel HM, Stringer JS, Chi BH. J Acquir Immune Defic Syndr; 2016 Aug 01; 72 Suppl 2(Suppl 2):S145-53. PubMed ID: 27355502 [Abstract] [Full Text] [Related]
20. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Kesho Bora Study Group, de Vincenzi I. Lancet Infect Dis; 2011 Mar 01; 11(3):171-80. PubMed ID: 21237718 [Abstract] [Full Text] [Related] Page: [Next] [New Search]